UniProt ID | AGAP2_HUMAN | |
---|---|---|
UniProt AC | Q99490 | |
Protein Name | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 | |
Gene Name | AGAP2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1192 | |
Subcellular Localization |
Isoform 1: Cytoplasm. Nucleus. Isoform 2: Cytoplasm. |
|
Protein Description | GTPase-activating protein (GAP) for ARF1 and ARF5, which also shows strong GTPase activity. Isoform 1 participates in the prevention of neuronal apoptosis by enhancing PI3 kinase activity. It aids the coupling of metabotropic glutamate receptor 1 (GRM1) to cytoplasmic PI3 kinase by interacting with Homer scaffolding proteins, and also seems to mediate anti-apoptotic effects of NGF by activating nuclear PI3 kinase. Isoform 2 does not stimulate PI3 kinase but may protect cells from apoptosis by stimulating Akt. It also regulates the adapter protein 1 (AP-1)-dependent trafficking of proteins in the endosomal system. It seems to be oncogenic. It is overexpressed in cancer cells, prevents apoptosis and promotes cancer cell invasion.. | |
Protein Sequence | MSRGAGALQRRTTTYLISLTLVKLESVPPPPPSPSAAAVGAPGARGSEPRDPGSPRGAEEPGKKRHERLFHRQDALWISTSSAGAGGAEPPALSPAPASPARPVSPAPGRRLSLWAAPPGPPLSGGLSPDSKPGGAPSSSRRPLLSSPSWGGPEPEGRTGGGVPGSSSPHPGTGSRRLKVAPPPPAPKPCKTVTTSGAKAGGGKGAGSRLSWPESEGKPRVKGSKSSAGTGASVSAAATAAAAGGGGSTASTSGGVGAGAGARGKLSPRKGKSKTLDNSDLHPGPPAGSPPPLTLPPTPSPATAVTAASAQPPGPAPPITLEPPAPGLKRGREGGRASTRDRKMLKFISGIFTKSTGGPPGSGPLPGPPSLSSGSGSRELLGAELRASPKAVINSQEWTLSRSIPELRLGVLGDARSGKSSLIHRFLTGSYQVLEKTESEQYKKEMLVDGQTHLVLIREEAGAPDAKFSGWADAVIFVFSLEDENSFQAVSRLHGQLSSLRGEGRGGLALALVGTQDRISASSPRVVGDARARALCADMKRCSYYETCATYGLNVDRVFQEVAQKVVTLRKQQQLLAACKSLPSSPSHSAASTPVAGQASNGGHTSDYSSSLPSSPNVGHRELRAEAAAVAGLSTPGSLHRAAKRRTSLFANRRGSDSEKRSLDSRGETTGSGRAIPIKQSFLLKRSGNSLNKEWKKKYVTLSSNGFLLYHPSINDYIHSTHGKEMDLLRTTVKVPGKRPPRAISAFGPSASINGLVKDMSTVQMGEGLEATTPMPSPSPSPSSLQPPPDQTSKHLLKPDRNLARALSTDCTPSGDLSPLSREPPPSPMVKKQRRKKLTTPSKTEGSAGQAEAKRKMWKLKSFGSLRNIYKAEENFEFLIVSSTGQTWHFEAASFEERDAWVQAIESQILASLQCCESSKVKLRTDSQSEAVAIQAIRNAKGNSICVDCGAPNPTWASLNLGALICIECSGIHRNLGTHLSRVRSLDLDDWPRELTLVLTAIGNDTANRVWESDTRGRAKPSRDSSREERESWIRAKYEQLLFLAPLSTSEEPLGRQLWAAVQAQDVATVLLLLAHARHGPLDTSVEDPQLRSPLHLAAELAHVVITQLLLWYGADVAARDAQGRTALFYARQAGSQLCADILLQHGCPGEGGSAATTPSAATTPSITATPSPRRRSSAASVGRADAPVALV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSRGAGALQ ------CCCCCHHCH | 51.21 | - | |
3 | Methylation | -----MSRGAGALQR -----CCCCCHHCHH | 51.33 | - | |
35 | Phosphorylation | PPPPPSPSAAAVGAP CCCCCCCCHHCCCCC | 34.57 | 19690332 | |
113 | Phosphorylation | PAPGRRLSLWAAPPG CCCCCEEEEEECCCC | 21.76 | - | |
128 | Phosphorylation | PPLSGGLSPDSKPGG CCCCCCCCCCCCCCC | 29.90 | - | |
138 | Phosphorylation | SKPGGAPSSSRRPLL CCCCCCCCCCCCCCC | 40.17 | 28787133 | |
140 | Phosphorylation | PGGAPSSSRRPLLSS CCCCCCCCCCCCCCC | 36.32 | 22210691 | |
146 | Phosphorylation | SSRRPLLSSPSWGGP CCCCCCCCCCCCCCC | 48.13 | 24732914 | |
147 | Phosphorylation | SRRPLLSSPSWGGPE CCCCCCCCCCCCCCC | 23.95 | 24732914 | |
149 | Phosphorylation | RPLLSSPSWGGPEPE CCCCCCCCCCCCCCC | 40.06 | 26437602 | |
208 | Phosphorylation | GGGKGAGSRLSWPES CCCCCCCCCCCCCHH | 29.52 | 25332170 | |
211 | Phosphorylation | KGAGSRLSWPESEGK CCCCCCCCCCHHCCC | 39.20 | 25307156 | |
224 | Phosphorylation | GKPRVKGSKSSAGTG CCCCCCCCCCCCCCC | 24.52 | 28857561 | |
226 | Phosphorylation | PRVKGSKSSAGTGAS CCCCCCCCCCCCCHH | 27.41 | 28857561 | |
227 | Phosphorylation | RVKGSKSSAGTGASV CCCCCCCCCCCCHHH | 34.16 | 22210691 | |
233 | Phosphorylation | SSAGTGASVSAAATA CCCCCCHHHHHHHHH | 20.25 | 22210691 | |
235 | Phosphorylation | AGTGASVSAAATAAA CCCCHHHHHHHHHHH | 15.08 | 28787133 | |
248 | Phosphorylation | AAAGGGGSTASTSGG HHCCCCCCCCCCCCC | 24.87 | 22817900 | |
249 | Phosphorylation | AAGGGGSTASTSGGV HCCCCCCCCCCCCCC | 28.09 | 23403867 | |
251 | Phosphorylation | GGGGSTASTSGGVGA CCCCCCCCCCCCCCC | 24.16 | 22210691 | |
252 | Phosphorylation | GGGSTASTSGGVGAG CCCCCCCCCCCCCCC | 29.00 | 22817900 | |
253 | Phosphorylation | GGSTASTSGGVGAGA CCCCCCCCCCCCCCC | 30.93 | 23403867 | |
267 | Phosphorylation | AGARGKLSPRKGKSK CCCCCCCCCCCCCCC | 26.58 | 23532336 | |
403 | Phosphorylation | QEWTLSRSIPELRLG HHHHHCCCCCCCEEC | 38.84 | 24719451 | |
431 | Phosphorylation | HRFLTGSYQVLEKTE HHHHHCCHHHHHHCC | 12.18 | 24076635 | |
498 | Phosphorylation | SRLHGQLSSLRGEGR HHHHHHHHHHCCCCC | 21.31 | 30301811 | |
499 | Phosphorylation | RLHGQLSSLRGEGRG HHHHHHHHHCCCCCC | 30.58 | 25954137 | |
505 | Methylation | SSLRGEGRGGLALAL HHHCCCCCCHHEEEE | 31.53 | - | |
520 | Phosphorylation | VGTQDRISASSPRVV EECCCCCCCCCCCHH | 24.00 | 26699800 | |
522 | Phosphorylation | TQDRISASSPRVVGD CCCCCCCCCCCHHCH | 33.80 | 24719451 | |
523 | Phosphorylation | QDRISASSPRVVGDA CCCCCCCCCCHHCHH | 19.22 | 30576142 | |
540 | Ubiquitination | RALCADMKRCSYYET HHHHCHHCCCCHHHH | 51.29 | - | |
544 | Phosphorylation | ADMKRCSYYETCATY CHHCCCCHHHHHHHH | 14.67 | - | |
545 | Phosphorylation | DMKRCSYYETCATYG HHCCCCHHHHHHHHC | 6.62 | - | |
565 | Ubiquitination | VFQEVAQKVVTLRKQ HHHHHHHHHHHHHHH | 29.00 | - | |
571 | Ubiquitination | QKVVTLRKQQQLLAA HHHHHHHHHHHHHHH | 56.42 | - | |
581 | Phosphorylation | QLLAACKSLPSSPSH HHHHHHHCCCCCCCC | 45.45 | 28450419 | |
584 | Phosphorylation | AACKSLPSSPSHSAA HHHHCCCCCCCCCCC | 61.24 | 28450419 | |
585 | Phosphorylation | ACKSLPSSPSHSAAS HHHCCCCCCCCCCCC | 28.60 | 28450419 | |
587 | Phosphorylation | KSLPSSPSHSAASTP HCCCCCCCCCCCCCC | 31.83 | 28450419 | |
589 | Phosphorylation | LPSSPSHSAASTPVA CCCCCCCCCCCCCCC | 29.84 | 28464451 | |
592 | Phosphorylation | SPSHSAASTPVAGQA CCCCCCCCCCCCCCC | 32.72 | 27080861 | |
593 | Phosphorylation | PSHSAASTPVAGQAS CCCCCCCCCCCCCCC | 19.63 | 28450419 | |
600 | Phosphorylation | TPVAGQASNGGHTSD CCCCCCCCCCCCCCC | 28.28 | 23401153 | |
605 | Phosphorylation | QASNGGHTSDYSSSL CCCCCCCCCCCCCCC | 26.94 | 28450419 | |
606 | Phosphorylation | ASNGGHTSDYSSSLP CCCCCCCCCCCCCCC | 28.95 | 28450419 | |
608 | Phosphorylation | NGGHTSDYSSSLPSS CCCCCCCCCCCCCCC | 15.37 | 28450419 | |
609 | Phosphorylation | GGHTSDYSSSLPSSP CCCCCCCCCCCCCCC | 20.59 | 23401153 | |
610 | Phosphorylation | GHTSDYSSSLPSSPN CCCCCCCCCCCCCCC | 29.66 | 28450419 | |
611 | Phosphorylation | HTSDYSSSLPSSPNV CCCCCCCCCCCCCCC | 38.06 | 28464451 | |
614 | Phosphorylation | DYSSSLPSSPNVGHR CCCCCCCCCCCCCCH | 64.82 | 23401153 | |
615 | Phosphorylation | YSSSLPSSPNVGHRE CCCCCCCCCCCCCHH | 20.67 | 28450419 | |
634 | Phosphorylation | AAAVAGLSTPGSLHR HHHHHCCCCHHHHHH | 31.47 | 28450419 | |
635 | Phosphorylation | AAVAGLSTPGSLHRA HHHHCCCCHHHHHHH | 36.39 | 23401153 | |
638 | Phosphorylation | AGLSTPGSLHRAAKR HCCCCHHHHHHHHHH | 23.39 | 23401153 | |
647 | Phosphorylation | HRAAKRRTSLFANRR HHHHHHHHHHHCCCC | 33.54 | 30266825 | |
648 | Phosphorylation | RAAKRRTSLFANRRG HHHHHHHHHHCCCCC | 21.48 | 23401153 | |
656 | Phosphorylation | LFANRRGSDSEKRSL HHCCCCCCHHHCCCC | 35.83 | 22817900 | |
679 | Ubiquitination | SGRAIPIKQSFLLKR CCCEEECCHHEEECC | 34.24 | - | |
681 | Phosphorylation | RAIPIKQSFLLKRSG CEEECCHHEEECCCC | 16.92 | 28122231 | |
682 (in isoform 2) | Phosphorylation | - | 9.55 | 16841086 | |
685 | Methylation | IKQSFLLKRSGNSLN CCHHEEECCCCCCCC | 46.82 | - | |
690 | Phosphorylation | LLKRSGNSLNKEWKK EECCCCCCCCHHHHH | 36.52 | 29978859 | |
734 | Ubiquitination | DLLRTTVKVPGKRPP EEEEEEEECCCCCCC | 40.39 | - | |
745 | Phosphorylation | KRPPRAISAFGPSAS CCCCCCHHHCCCCCH | 19.29 | 26074081 | |
750 | Phosphorylation | AISAFGPSASINGLV CHHHCCCCCHHCCHH | 34.72 | 26074081 | |
752 | Phosphorylation | SAFGPSASINGLVKD HHCCCCCHHCCHHCC | 22.41 | 26074081 | |
774 (in isoform 2) | Phosphorylation | - | 28.47 | 16841086 | |
808 | Phosphorylation | RNLARALSTDCTPSG HHHHHHHCCCCCCCC | 22.63 | 23401153 | |
809 | Phosphorylation | NLARALSTDCTPSGD HHHHHHCCCCCCCCC | 35.62 | 30266825 | |
812 | Phosphorylation | RALSTDCTPSGDLSP HHHCCCCCCCCCCCC | 24.25 | 30266825 | |
814 | Phosphorylation | LSTDCTPSGDLSPLS HCCCCCCCCCCCCCC | 27.13 | 30266825 | |
818 | Phosphorylation | CTPSGDLSPLSREPP CCCCCCCCCCCCCCC | 28.65 | 28122231 | |
821 | Phosphorylation | SGDLSPLSREPPPSP CCCCCCCCCCCCCCC | 37.67 | 28122231 | |
827 | O-linked_Glycosylation | LSREPPPSPMVKKQR CCCCCCCCCCCCHHH | 31.25 | 30379171 | |
827 | Phosphorylation | LSREPPPSPMVKKQR CCCCCCCCCCCCHHH | 31.25 | 23401153 | |
831 | Acetylation | PPPSPMVKKQRRKKL CCCCCCCCHHHHHCC | 36.62 | 7704497 | |
832 | Acetylation | PPSPMVKKQRRKKLT CCCCCCCHHHHHCCC | 37.31 | 6570039 | |
839 | Phosphorylation | KQRRKKLTTPSKTEG HHHHHCCCCCCCCCC | 45.61 | 28060719 | |
894 | Phosphorylation | TWHFEAASFEERDAW EEEEEECCHHHHHHH | 39.99 | 24719451 | |
925 | Phosphorylation | SSKVKLRTDSQSEAV HCCEEEECCCHHHHH | 50.90 | 30266825 | |
927 | Phosphorylation | KVKLRTDSQSEAVAI CEEEECCCHHHHHHH | 34.69 | 23401153 | |
929 | Phosphorylation | KLRTDSQSEAVAIQA EEECCCHHHHHHHHH | 31.32 | 30266825 | |
985 | Phosphorylation | THLSRVRSLDLDDWP HHHHHCCCCCCCCCC | 24.31 | 24247654 | |
1006 | Phosphorylation | LTAIGNDTANRVWES EEEECCCHHHCCCCC | 29.81 | - | |
1037 | Ubiquitination | RESWIRAKYEQLLFL HHHHHHHHHHHHHHH | 39.20 | - | |
1038 | Phosphorylation | ESWIRAKYEQLLFLA HHHHHHHHHHHHHHE | 14.13 | 16841086 | |
1130 | Phosphorylation | QGRTALFYARQAGSQ CCCHHHHHHHHHHCH | 11.17 | 16841086 | |
1154 | Phosphorylation | GCPGEGGSAATTPSA CCCCCCCCCCCCCCC | 26.11 | 26074081 | |
1157 | Phosphorylation | GEGGSAATTPSAATT CCCCCCCCCCCCCCC | 38.67 | 26074081 | |
1158 | Phosphorylation | EGGSAATTPSAATTP CCCCCCCCCCCCCCC | 15.54 | 26074081 | |
1160 | Phosphorylation | GSAATTPSAATTPSI CCCCCCCCCCCCCCC | 28.57 | 26074081 | |
1163 | Phosphorylation | ATTPSAATTPSITAT CCCCCCCCCCCCCCC | 38.67 | 26074081 | |
1164 | Phosphorylation | TTPSAATTPSITATP CCCCCCCCCCCCCCC | 15.43 | 26074081 | |
1166 | Phosphorylation | PSAATTPSITATPSP CCCCCCCCCCCCCCC | 30.40 | 26074081 | |
1168 | Phosphorylation | AATTPSITATPSPRR CCCCCCCCCCCCCCC | 28.90 | 23401153 | |
1170 | Phosphorylation | TTPSITATPSPRRRS CCCCCCCCCCCCCCC | 18.69 | 26074081 | |
1172 | Phosphorylation | PSITATPSPRRRSSA CCCCCCCCCCCCCCC | 27.04 | 26074081 | |
1177 | Phosphorylation | TPSPRRRSSAASVGR CCCCCCCCCCCCCCC | 23.63 | 30576142 | |
1178 | Phosphorylation | PSPRRRSSAASVGRA CCCCCCCCCCCCCCC | 26.49 | 30576142 | |
1181 | Phosphorylation | RRRSSAASVGRADAP CCCCCCCCCCCCCCC | 25.48 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
249 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
279 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
472 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
629 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
682 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
774 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AGAP2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AGAP2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
E41L1_HUMAN | EPB41L1 | physical | 11136977 | |
P85A_HUMAN | PIK3R1 | physical | 11136977 | |
MPRIP_HUMAN | MPRIP | physical | 20368287 | |
MPRIP_MOUSE | Mprip | physical | 20368287 | |
NR4A1_MOUSE | Nr4a1 | physical | 20368287 | |
SIA1A_MOUSE | Siah1a | physical | 20368287 | |
GRIP1_HUMAN | GRIP1 | physical | 21847098 | |
GRIA2_HUMAN | GRIA2 | physical | 21847098 | |
CDC42_HUMAN | CDC42 | physical | 22453919 | |
RAC1_HUMAN | RAC1 | physical | 22453919 | |
RAC2_HUMAN | RAC2 | physical | 22453919 | |
RHOA_HUMAN | RHOA | physical | 22453919 | |
RAC1_MOUSE | Rac1 | physical | 22453919 | |
ARF1_HUMAN | ARF1 | physical | 22453919 | |
AKT1_HUMAN | AKT1 | physical | 22450747 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-635 AND SER-638, ANDMASS SPECTROMETRY. |